Genelux Corporation (GNLX)
NASDAQ: GNLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
GNLX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $114.02M
- EPS (TTM)
- -$0.86
- Dividend yield
- None
- 52-week range
- 2.29 – 8.54
- Day range
- 2.46 – 2.59
- Volume / Avg
- 550.94K / 268.26K
- Beta
- —
- Shares outstanding
- 45.25M
- Next earnings
- Nov 4, 2026
52-week range
GNLX stock today
Genelux (GNLX) closed at $2.52 on Oct 7, down 0.79% (-$0.02), versus the S&P 500's 0.22% decline. Volume was 2.1x the average at 550.94K shares, a sign of unusually heavy trading. Shares are 70.5% below their 52-week high of $8.54, set on Nov 5, 2025 and 10.0% above the 52-week low of $2.29, near the bottom of the past year's range.
GNLX is down 42.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 46.5%. Genelux has posted a net loss over the last twelve months (EPS of -$0.86), so its P/E ratio is not meaningful. Genelux's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Genelux
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2023
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.20
Genelux peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| COYACoya Therapeutics Inc. | 4.91 | +1.24% | $115.18M | vs GNLX |
| UNCYUnicycive Therapeutics Inc. | 4.18 | -1.18% | $114.50M | vs GNLX |
| RANIRani Therapeutics Holdings Inc. Class A | 0.8121 | -2.02% | $114.12M | vs GNLX |
| PMVPPMV Pharmaceuticals Inc. | 1.50 | -6.83% | $113.27M | vs GNLX |
| INOInovio Pharmaceuticals Inc. | 1.16 | +2.21% | $119.42M | vs GNLX |
| QUCYQuantum Cyber N.V. | 1.43 | +10.85% | $120.22M | vs GNLX |
| AARDAardvark Therapeutics Inc. | 4.96 | -1.59% | $108.55M | vs GNLX |
| VTVTvTv Therapeutics Inc. Class A | 31.01 | +3.26% | $122.61M | vs GNLX |
Indexes, lists and sector
Genelux stock FAQ
What is Genelux's stock price today?
GNLX last traded at $2.52 as of Oct 7, 4:00 PM EDT, down 0.79% on the day. Prices are delayed at least 15 minutes.
When is Genelux's next earnings date?
Genelux is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.20.
What is the GNLX 52-week high?
The 52-week high for GNLX is $8.54 and the 52-week low is $2.29. The stock is currently 70.5% below its high.